Endocrinology & Diabetes

Welcome message

About conference

The 23^rd World Congress on Endocrinology & Diabetes will take place on June 29-30, 2027, in Paris, France, bringing together a distinguished gathering of global leaders, scientists, clinicians, academicians, and industry partners. The conference aims to address the most pressing challenges facing endocrinology and diabetes care through robust scientific discussions, knowledge exchange, and collaborative initiatives.

This year’s congress will highlight advancements across endocrinology—including hormone disorders, metabolic syndrome, reproductive endocrinology, thyroid disease, adrenal pathologies, obesity science, and diabetes innovation. The scientific program features keynote talks, symposiums, interactive workshops, oral and poster sessions, case discussions, and industry-led showcases.

With an emphasis on precision medicine, digital health, AI-powered diagnostics, cutting-edge therapeutics, and real-world clinical solutions, the congress provides a comprehensive platform for attendees across academia, clinical practice, and industry.

Why to attend

Attending the 23^rd World Congress on Endocrinology & Diabetes offers unparalleled advantages:

• Gain insights into cutting-edge advances in diabetes management, endocrine disorders, metabolic science, obesity therapeutics, reproductive health, and precision medicine.
• Learn from global experts leading groundbreaking research, clinical guidelines, and technology-driven solutions in endocrinology.
• Build lasting professional networks with clinicians, researchers, industry representatives, academicians, and policymakers from over 40 countries.
• Present your research to a global audience to enhance academic visibility and professional credibility.
• Explore emerging themes such as AI-assisted diabetic diagnostics, digital metabolic health tools, insulin innovations, wearable monitoring, hormone replacement advancements, and targeted metabolic therapies.
• Participate in interactive workshops designed to translate clinical evidence into effective practice.

Experience Paris - its science, culture, cuisine, and timeless architecture - while engaging in high-level scientific exchange.

Sessions & Tracks

1. The GLP-1 Revolution: Beyond Weight Loss & Glycemic Control

Explore the rapidly evolving world of GLP-1 receptor agonists and next-generation incretin therapies. Sessions can examine cardio metabolic benefits, safety, muscle preservation, weight regain and long-term outcomes. Special focus on combination incretin therapies and where obesity medicine is heading next. Current endocrine congress programming is already placing strong emphasis on the biology, safety and value of GLP-1 therapies.

2. Precision Metabolic Medicine: One Patient, One Metabolic Signature

Move beyond “one-size-fits-all” diabetes and obesity management through metabotyping and patient stratification. Explore genomics, metabolomics, biomarkers, micro biome signatures and AI-driven risk prediction. Discover how precision phenol typing can guide drug selection and personalized lifestyle interventions. The goal: transforming metabolic medicine from population-based treatment to individualized care.

3. AI Meets Endocrinology: From Algorithms to Clinical Decisions

Discover how artificial intelligence is reshaping diagnosis, prediction and treatment across endocrinology. Topics include AI-assisted imaging, automated glucose interpretation, predictive analytics and clinical decision support. Debate the opportunities—and limitations—of AI in real-world endocrine practice. A special focus can address bias, explain ability, patient privacy and responsible AI.

4. Diabetes 2030: The Future beyond Insulin

Examine next-generation therapies transforming Type 1 and Type 2 diabetes care.
Cover smart insulin delivery, glucose-responsive therapies, beta-cell replacement, immune therapy and disease-modifying approaches. Explore how continuous glucose monitoring and connected devices are changing clinical decision-making.

5. Obesity Unfiltered: Biology, Brain, Behavior & Breakthrough Therapies

Go beyond BMI to explore obesity as a complex neuroendocrine and metabolic disease. Discuss appetite regulation, adipose tissue biology, gut-brain signaling, genetics and environmental influences. Compare pharmacotherapy, metabolic surgery, nutrition and behavioral interventions. Include the emerging challenge of maintaining muscle mass and preventing weight regain.

6. MASLD & Metabolic Liver Disease: The Liver–Endocrine Connection

Explore the intersection between obesity, insulin resistance, diabetes and metabolic dysfunction-associated steatotic liver disease. Discuss emerging biomarkers, non-invasive diagnostics and novel therapeutic strategies. Highlight the role of endocrinologists in identifying and managing metabolic liver disease. Create a multidisciplinary bridge between endocrinology, hepatology, cardiology and primary care.

7. The Gut–Hormone–Brain Axis: Micro biome to Metabolism

Unpack the fascinating relationship between gut microbes, hormones, appetite and metabolic health. Sessions can explore incretins, bile acids, microbial metabolites and gut-brain communication. Examine whether micro biome-based interventions can become clinically meaningful metabolic therapies. Bridge basic science discoveries with practical applications in obesity and diabetes care.

8. Endocrine Disruptors & Planetary Health

Investigate how plastics, PFAS, pesticides, heavy metals and other environmental exposures influence endocrine and metabolic health. Explore links with obesity, diabetes, reproductive disorders, thyroid disease and developmental outcomes. Bring environmental scientists, endocrinologists and policymakers into the same conversation. End with actionable strategies for prevention, regulation and healthier environments.

9. Next-Gen Endocrine Therapeutics: From Molecules to Medicines

Showcase emerging drug classes, novel hormone analogues, receptor modulators and targeted therapies. Explore how molecular biology and translational research are accelerating endocrine drug discovery. Include first-in-human studies, innovative clinical trial designs and real-world evidence. A “pipeline to practice” format can make this track especially attractive to researchers and industry.

10. Beta Cells under the Microscope: Repair, Replace, Reprogram

Focus on the biology of pancreatic beta-cell failure and possibilities for restoration. Discuss stem-cell-derived islets, transplantation, immune protection and beta-cell regeneration. Explore strategies aimed at preserving endogenous insulin production in early diabetes. Bring together basic scientists, clinicians and biotechnology innovators.

Participation and Presentation Options

To support diverse global participants, the 2027 Congress offers multiple presentation formats:

Oral Presentation: Present full research studies, clinical outcomes, analytical discoveries, innovative diagnostics, or therapeutic advancements in endocrinology and diabetes. Engage with experts through Q&A sessions.

Poster Presentation: Ideal for preliminary findings, methodological advances, case studies, or ongoing projects. Dedicated poster walks encourage scientific dialogue and feedback.

Virtual Presentation: Designed for those unable to travel. Receive equal recognition, certificates, and program inclusion.

Delegate Participation: Attend all scientific sessions, workshops, and panels without presenting.

Exhibitor & Sponsorship Opportunities: Perfect for biotechnology companies, diagnostics firms, startups, pharmaceutical industries, academic institutions, and medical device firms. Showcase innovative products, tools, and technologies to a global audience.

PARTICIPATION AND PRESENTATION OPTIONS:

Knowledge Enhancement & Skill Development

• Learn from leading endocrinologists, diabetologists, metabolic scientists, and digital health innovators.
• Gain exposure to breakthrough research in insulin analogs, glucose monitoring technologies, endocrine biomarkers, metabolic genetics, reproductive endocrinology, and obesity therapeutics.
• Participate in workshops on clinical best practices, AI-driven diagnostics, multi-omics metabolic profiling, and innovative treatment frameworks.

• Meet professionals from more than 40 countries.
• Build collaborations for joint research, publications, funding, and institutional partnerships.
• Connect with mentors, peers, and industry leaders shaping the future of metabolic health.

• Strengthen academic and professional credibility.
• Learn about evolving global guidelines, clinical strategies, and regulatory pathways in endocrinology and diabetes.
• Build competencies in research communication, scientific writing, and clinical innovation.

Enjoy access to:

• Keynote lectures
• Oral sessions
• Poster presentations
• Technical workshops
• Industry demonstrations
• Panel discussions

• Receive official invitation letters for visa processing.
• If unable to travel, switch to virtual participation without deduction.
• Registration may also be transferred to future editions.

Institutions gain:

• Global visibility
• Collaboration prospects
• Access to new technologies and clinical tools

• Certificate of Participation
• Certificate of Presentation (for presenters)
• Official endorsement from the 23^rd World Congress on Endocrinology & Diabetes

Abstract Review Process

Our structured and transparent abstract evaluation ensures quality and relevance:

Submission: Abstracts are submitted through the official online portal.

Pre-Screening: Editors check relevance, format, and clarity.

Double-Blind Peer Review: Evaluated by two independent experts in endocrinology, diabetes, or related specialties.

Scoring Criteria:

1. Scientific merit and originality
2. Methodological soundness
3. Clinical relevance
4. Alignment with conference themes

Decision & Notification: Authors receive acceptance confirmation for Oral, Poster, or Virtual format.

Early Submission Advantage: Early abstracts receive preferred presentation slots and enhanced program visibility.

Market Analysis

The global endocrinology and diabetes landscape is expanding rapidly due to rising disease prevalence, technological advancements, and growing demand for personalized care.

• The global diabetes care market is projected to exceed USD 100 billion by 2030, driven by insulin innovations, glucose monitoring systems, and digital health tools.
• Continuous glucose monitoring (CGM) and insulin pump technologies show strong annual growth, largely due to improved accuracy and patient adoption.
• The endocrine disorder therapeutics market continues to grow steadily, driven by thyroid, adrenal, and reproductive hormone therapies.
• Obesity therapeutics, including GLP-1 receptor agonists and metabolic agents, represent one of the fastest-growing global health markets.
• Advances in AI-based diagnostics, tele-endocrinology, wearable metabolic monitors, and personalized hormone therapies are reshaping global patient care.
• Increased investment in genomics, metabolic research, and digital health ecosystems offers new opportunities for scientific and industrial collaborations.

The congress provides a vital platform for researchers, clinicians, and industry leaders to align with evolving market trends and contribute to the future of endocrinology and diabetes innovation.